Magenta Medical vs Moderna
Side-by-side comparison of AI visibility scores, market position, and capabilities
Magenta Medical is developing the Elevate pLVAD, the world's smallest percutaneous heart pump — FDA Breakthrough Device for HR-PCI and cardiogenic shock; raised $105M Series C in 2023.
About
Magenta Medical is an Israel-based medical device company developing a miniaturized percutaneous Left Ventricular Assist Device (pLVAD) to provide temporary mechanical circulatory support for patients with acute cardiac conditions. Founded and headquartered in Israel, the company''s flagship product, the Elevate™ heart pump, is inserted via an 8-French catheter over a guidewire — making it one of the least invasive cardiac support devices ever developed. It can deliver more than 5 L/min of hemodynamic support.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
About
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
AI Visibility Head-to-Head
Key Details
Also Compare
Magenta Medical vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.